| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.1M | +49.3% |
| R&D Expense | $77.2M | -3.5% |
| SG&A Expense | $26.2M | +20.0% |
| Operating Income | -$100.3M | +2.4% |
| Interest Expense | $1.8M | +39.0% |
| Income Tax | $0 | — |
| Net Income | -$97.4M | +5.1% |
| EPS (Basic) | -$1.80 | +15.9% |
| EPS (Diluted) | -$1.80 | +15.9% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $68.4M | -3.1% |
| Short-term Investments | $5.0M | -90.8% |
| Accounts Receivable | $5.1M | — |
| Current Assets | $89.9M | -34.7% |
| Total Assets | $204.4M | +40.0% |
| Current Liabilities | $26.8M | +22.0% |
| Long-term Debt | $18.9M | -5.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$91.5M | +7.1% |
| Capital Expenditures | $2.9M | +107.9% |
| Investing Cash Flow | $47.5M | +363.1% |
| Financing Cash Flow | $41.8M | +5807.2% |
| Free Cash Flow | -$94.4M | +5.5% |
| Total Liabilities |
| $146.3M |
| +265.6% |
| Stockholders' Equity | $58.0M | -45.3% |